(IMCV) iShares Morningstar Mid-Cap - Ratings and Ratios
Mid-Cap Stocks, Value Stocks, U.S. Equities
Dividends
| Dividend Yield | 2.17% |
| Yield on Cost 5y | 3.95% |
| Yield CAGR 5y | -19.03% |
| Payout Consistency | 91.8% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 13.1% |
| Value at Risk 5%th | 21.5% |
| Relative Tail Risk | -0.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -2.34 |
| CAGR/Max DD | 0.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.392 |
| Beta | 0.753 |
| Beta Downside | 0.866 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.63% |
| Mean DD | 4.33% |
| Median DD | 3.06% |
Description: IMCV iShares Morningstar Mid-Cap December 01, 2025
The iShares Morningstar Mid-Cap Value ETF (NASDAQ: IMCV) aims to track an index that captures U.S. mid-cap stocks identified as “value” by Morningstar’s proprietary methodology. The fund commits at least 80 % of its assets to the index’s component securities or to securities that are economically equivalent, ensuring tight alignment with the underlying benchmark.
Key metrics as of the most recent filing: expense ratio ≈ 0.20 %, 12-month trailing dividend yield ≈ 2.3 %, and an average market-cap range of $2 billion–$10 billion. The top sector allocations are Financials (≈ 25 %), Industrials (≈ 22 %) and Consumer Discretionary (≈ 18 %), sectors that historically benefit from a rising interest-rate environment and resilient domestic spending. Over the past 12 months the ETF has outperformed the broader S&P 500 Mid-Cap Index by roughly 1.5 % on a total-return basis, reflecting the relative strength of value-oriented mid-cap equities in the current earnings cycle.
If you’re interested in a deeper quantitative comparison of IMCV’s risk-adjusted performance versus other value-focused ETFs, a quick look at ValueRay’s analytics dashboard can provide the data you need.
What is the price of IMCV shares?
Over the past week, the price has changed by +1.31%, over one month by +2.66%, over three months by +4.49% and over the past year by +10.09%.
Is IMCV a buy, sell or hold?
What are the forecasts/targets for the IMCV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 93.3 | 11.9% |
IMCV Fundamental Data Overview December 02, 2025
Beta = 1.02
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 896.1m USD (896.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 896.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 896.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.79% (E(896.1m)/V(896.1m) * Re(8.79%) + (debt-free company))
Discount Rate = 8.79% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IMCV ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle